Simpler Grants.gov #PAR-25-167

NCI Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is inviting applications for clinical trials under the Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required). - Focus is on investigator-initiated clinical trials to reduce cancer burden through: - Early detection, screening, prevention, and interception - Improvements in healthcare delivery, quality of life, and survivorship - Trials related to cancer diagnosis and oncologic therapy are explicitly excluded - Eligible applicants include: - For-profit and nonprofit organizations - Educational institutions - Government agencies and tribal organizations - No specific OEMs, vendors, products, or part numbers are identified - Program aligns with NCI Division of Cancer Prevention and Division of Cancer Control and Population Sciences priorities

Description

The National Cancer Institute (NCI) invites applications for investigator-initiated clinical trials aimed at reducing the burden of cancer through improvements in early detection, screening, prevention, healthcare delivery, quality of life, and survivorship. The studies should have the potential to improve clinical practice and public health and must meet the NIH definition of a clinical trial. This funding opportunity excludes clinical trials focused on cancer diagnosis and oncologic therapy in patients. The projects should align with the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

View original listing